GeoSpock enables data fusion for the connected world with GeoSpock DB – the space-time analytics database. GeoSpock DB is a unique, cloud-native database optimised for querying for real-world use cases, able to fuse multiple sources of Internet of Things (IoT) data together to unlock its full value, whilst simultaneously reducing complexity and cost. GeoSpock DB enables efficient storage, data fusion, and rapid programmatic access to data, and allows you to run ANSI SQL queries and connect to standard analytics tools via flexible JDBC/ODBC connectors. Users are able to perform deep analysis and share insights using familiar toolsets, with plug and play support for common BI tools (such as Tableau™, Amazon QuickSight™, and Microsoft Power BI™), and Data Science and Machine Learning environments (including Python Notebooks and Apache Spark). The database can also be integrated with proprietary applications, web services, and internal tools – with compatibility for open-source and customisable visualisation libraries such as Kepler and Cesium.js.
Wandercraft develops and sells the first exoskeleton to walk self-balanced, providing a realistic gait without crutches or technical aids. Its first commercial version, Atalante, was CE-marked in 2019 and is sold to European rehab hospitals to improve gait re-learning treatments. As of June 2020, FDA approval is on the way. The company develops a slimmer, sleeker and agile Personal Mobility exo for daily life usage. Wandercraft is a full-stack company integrating competencies in algorithmics, AI, robotics, production, clinical, marketing and sales. Wandercraft's exo is the first realistic, autonomous walking device for the walking impaired and also likely the first bipedal walking robot to be a commercial product and not a lab prototype.
BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer la recherche sur l'épilepsie et améliorer le futur du diagnostic
Private Equity Round in 2017
OpenHealth is a provider of real-time processing of health consumption data.
Ekinops is a provider of next-generation optical transport solutions for service providers and private networks. Its carrier-grade solutions leverage expertise in 10G transmission, aggregation and Forward Error Correction (FEC) to allow operators to cost-effectively increase data transport capacity over dark fiber, CWDM, DWDM, SONET/SDH, IP and SAN networks.
Paragon ID is a leader in identification solutions in the e-ID, transport, smart cities, traceability & brand protection sectors. Using the latest technologies such as RFID and NFC, Paragon ID provides smart cards, tickets, labels and tags to worldwide clients in diverse markets including public transport, manufacturing, logistics, gaming and retail. Paragon ID employs more than 600 staff, with manufacturing sites in three continents (US, Europe and Asia), close to its customers. Paragon ID is a part of Paragon Group, which is a leading provider of identification and customer communications services, and has a total turnover in excess of €650 million, and close to 5,000 employees. The Group combines generations of experience, with the latest innovations in technology and smart data, to enable responsive and meaningful interactions, between organisations and their customers.
Kayentis, a global leader in eCOA and Decentralized Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in over 200 indications across more than 20 therapeutic areas. Adapting to the changing landscape, Kayentis is now offering a comprehensive suite of services to support science-driven and patient-centric clinical research, with operational capabilities across the USA, Europe, and Asia.
Founded in 2008, H4D has remained true to its original mission: to overcome isolation from health care, whether geographic or social, while supporting preventative medicine initiatives, as well as the treatment and the monitoring of chronic diseases. They are committed to ensuring that health checks become a straightforward and accessible recourse to everyone. Their pledge to provide health care solutions for everyone, regardless of their geographic location or social environments, coheres with Their respect or medical and paramedical professionals. H4D’s health programs are always integrated into a global health plan and are supported by systematic communication with local healthcare stakeholders.
BIOMODEX is an innovative medical technology company based in Paris and Boston using 3D printing to create tissue-like anatomical twins from medical images, for patient-specific rehearsal and advanced training. The anatomically accurate twin is designed to provide critical tactile feedback to users which, when paired with our simulated blood flow stations, offers a unique and tailored end to end physician experience.
EXPWAY is the world leader in Mobile Broadcast and Multicast Solutions. The company's fastest growing market is on LTE BROADCAST i.e. eMBMS. Expway provides eMBMS BM-SC SERVERs that allow the operator to create multicast streams, both live TV and push files in any format, and broadcast them at the LTE network. Its eMBMS MIDDLEWARE controls the LTE modem, and receives and decodes the broadcast streams on the device.
Wandercraft develops and sells the first exoskeleton to walk self-balanced, providing a realistic gait without crutches or technical aids. Its first commercial version, Atalante, was CE-marked in 2019 and is sold to European rehab hospitals to improve gait re-learning treatments. As of June 2020, FDA approval is on the way. The company develops a slimmer, sleeker and agile Personal Mobility exo for daily life usage. Wandercraft is a full-stack company integrating competencies in algorithmics, AI, robotics, production, clinical, marketing and sales. Wandercraft's exo is the first realistic, autonomous walking device for the walking impaired and also likely the first bipedal walking robot to be a commercial product and not a lab prototype.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.
Zesty is a multi-award winning European digital health company backed by a group of international VC funds, including Mangrove Capital, LBO France and Qualcomm Ventures. We offer a suite of patient facing digital tools to healthcare providers. Our clients are hospitals, clinics and general practice surgeries. They pay us an annual SaaS fee or a fee per patient. Our apps remove the friction from everyday health related tasks, like booking appointments with doctors, reading letters digitally and managing repeat drug prescriptions. Our Vision is to build the UK’s first fully transactional Personal Health Record enabling patients to be at the centre of their care. Our Mission is to help healthcare providers offer a truly digital experience, empowering patients to manage their care, share their data and be actively involved in their treatment pathways.
ittingBox was born in 2006, when cousins Ariel Choukroun and Benjamin Hakoun challenged themselves to successfully reinvent the traditional in-store mirror, and create a virtual one. This was after Ariel realized he needed Benjamin’s help with his next glasses purchase, because he couldn’t see himself in the optician's mirror! They set themselves the goal of improving the customer experience of others like Ariel, and those searching for their next pair of glasses in general. They also aimed to use this innovation to boost business for eyecare professionals.
Voluntis is a healthcare software company specialized in Patient Relationship Management (PRM). Their mission is to enable healthcare organizations to deliver outstanding patient monitoring and support services through the use of advanced information and communication technologies. Voluntis was founded in 2001 by three entrepreneurs who believed that innovative medical solutions built with advanced information technologies would improve medical real-life outcomes and thus increase healthcare system efficiency. This would transform patient lives, enhance medical practices and quality of care. Every day, Voluntis teams seek to invent secure, collaborative and patient-centric digital health solutions with a unique combination of web and mobile development excellence, medical and regulatory expertise and certified quality-oriented processes. With more than 600,000 patients managed and more than 50 programs deployed, their track record speaks for itself.
Aldebaran Robotics designs, manufactures, and sells autonomous humanoid robots for entertainment purposes. The robots are also used for reception, assistance, home care, and autism therapy. Aldebaran Robotics’ products include NAO: a 58-cm tall humanoid robot developed to serve as a friendly companion that moves, recognizes, hears, and talks to human beings; Pepper: a social robot that converses with humans, recognizes them, and reacts to their emotions while moving and living autonomously; and Romeo: a 140-cm humanoid robot intended to deepen research on assistance for the elderly and those who have lost autonomy that has the ability to open doors, climb stairs, and grab objects on a table. Aldebaran Robotics was founded in 2005 and is based in Paris, France.
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.
OMNIlife science, Inc. was founded in 1999 as an organization committed to the design, manufacture and distribution of high quality orthopaedic devices. Their corporate headquarters are located in Massachusetts.
ittingBox was born in 2006, when cousins Ariel Choukroun and Benjamin Hakoun challenged themselves to successfully reinvent the traditional in-store mirror, and create a virtual one. This was after Ariel realized he needed Benjamin’s help with his next glasses purchase, because he couldn’t see himself in the optician's mirror! They set themselves the goal of improving the customer experience of others like Ariel, and those searching for their next pair of glasses in general. They also aimed to use this innovation to boost business for eyecare professionals.
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions.
Radio Systemes Ingenierie
Series D in 2009
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.
Anevia is a software company that specializes in providing IPTV and over-the-top (OTT) solutions for live television, streaming video, time-shifted TV, and video-on-demand services. Founded in 2003 and headquartered in Gentilly, France, Anevia has established itself as a leader in the multiscreen video services market, with over 1,000 deployments across 70 countries and millions of users accessing more than 25,000 live channels. The company's offerings include video compression technologies, multiscreen IPTV head-ends, cloud DVRs, and CDN solutions, enabling viewers to access high-quality content, including 4K UHD, on various devices. Anevia serves a diverse clientele, including telecom and pay-TV operators, TV broadcasters, and video service providers in sectors such as hospitality, healthcare, and corporate environments. The company also provides professional services, support, and training to enhance its clients' operational capabilities.
Stantum, Inc. designs and manufactures multitouch surface controllers. Its products include Lemur, which is a control surface for audio and media applications; and DEXTER, a laptop sized control surface, which is used for controlling digital audio workstations. The company’s products are used by musicians, composers, discjockies, media artists, researchers, and developers. It offers its products through distributors and retailers internationally. The company was formerly known as JazzMutant SAS and changed its name in 2007. Stantum, Inc. was founded in 2002 and is based in Bordeaux, France with a liaison office in Tokyo, Japan.
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.
Introduction to cacaoTV cacaoTV is a software that allows to view a streaming audio video media (i.e. TV channels) based on Peer to Peer (P2P) technology. cacaoTV works by using P2P technology, thus everyone when viewing media with cacaoweb client, the viewers upload content at the same time the programs are downloaded and viewed. cacaoweb creates a local stream on localhost and that stream is then read by Windows Media Player, Real Player or other media players. Since all viewers will upload content when viewing media, everyone becomes a broadcaster (server) without the cost of traditional streaming. And hence, the more users are online, the faster the programs can be loaded. And it will automatically find different connection nodes and download stream data from the nearest location (nodes). The good thing is, stream data is buffering in the memory, not on the hard disk. Channel Availability and Reliability Currently, most of the media contents are TV channels from the USA, and it includes some subscribers-based international channel such as HBO, ESPN, National Geographic and etc. Lately there are some independent channels that broadcast selective collection of media, such as latest blockbuster movies, collection of movies from a celebrity, or whole series of a drama. This kind of channels is created by individual viewers. There are also some radio channels available. Ease of Use and Speed of cacaoTV Just download cacaoweb and install it, and you’re ready to jump on the bandwagon of P2P TV. cacaoweb is able to work perfectly and stream smoothly without any configuration.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.
TxCell, a spin off of Inserm (France's National Institute for Health and Medical Research) located in the technology park of Sophia Antipolis, near Nice in southern France, is developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technology platform based on the properties of Type 1 regulatory T lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II study in refractory Crohn's disease patients and has reported first positive results. The company plans to initiate a PhIIb study in the same patient population and bring a second product candidate into a PhI/II study in refractory rheumatoid arthritis patients.
EI-Technologies means integrating a human-sized group, with a high-quality management and teams who are experts in their field of activity.
Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company’s research and development activities focus on infectious diseases and cardiometabolic disorders, while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders. The company has strategic partnerships with miRagen Therapeutics, Shire PLC, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. As part of its broad patent estate, the company holds exclusive worldwide rights to manufacture, have manufactured and sell products that contain LNA as an active ingredient for studies performed with a view to obtaining marketing approval. Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.
Aldebaran Robotics designs, manufactures, and sells autonomous humanoid robots for entertainment purposes. The robots are also used for reception, assistance, home care, and autism therapy. Aldebaran Robotics’ products include NAO: a 58-cm tall humanoid robot developed to serve as a friendly companion that moves, recognizes, hears, and talks to human beings; Pepper: a social robot that converses with humans, recognizes them, and reacts to their emotions while moving and living autonomously; and Romeo: a 140-cm humanoid robot intended to deepen research on assistance for the elderly and those who have lost autonomy that has the ability to open doors, climb stairs, and grab objects on a table. Aldebaran Robotics was founded in 2005 and is based in Paris, France.
Citilog is a provider of advanced video-based monitoring and surveillance products that enable traffic, security, and safety management operators to identify incidents in real-time instead of traditional passive solutions that act only to verify an incident after it has already come and gone. Citilog offers solutions to address Road and Infrastructure Safety, Security, Mobility, and Sustainable Growth.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.
Nemoptic, an epaper display company, designs and manufactures superior-quality bistable liquid crystal displays (LCD) modules highly suitable for consumer and professional mobile devices.
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions.
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.
GRAITEC Advance is a Building Information Modeling (BIM) system that automates the entire structural design and construction documentation process from engineering design and structural analysis to member optimization, detailing and fabrication. GRAITEC Advance provides designers and detailers with an optimal working environment with tools to create and completely carry out their construction projects: optimization of construction materials, elimination of project inconsistencies, faster study turnaround time, automatic document creation, project history and tracking, fluid communication with project partners etc. Founded in 1986, GRAITEC is an Autodesk Platinum Partner in Europe and America and a long standing international Autodesk Partner and independent developer of high performance BIM Solutions for the AEC industry. Operating throughout 29 offices across 12 countries worldwide, GRAITEC offers its clients an extensive range of established software solutions combined with the full portfolio of Autodesk products and BIM suites which help address the most demanding projects needs and maximize productivity, efficiency and performance. GRAITEC is an innovation focused company whose products are used by more than 40,000 construction professionals worldwide.
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.
Ipracom SA develops software solutions focusing on PDA's and smart-phones. The company offers products such as Ipra*Cool and Ipra*PC that enable users to connect to PC's for accessing files or check e-mail. It also develops software for vertical applications. The company's clientele includes Orange, Bouygues Telecom, and Smart Communications. Ipracom is based in Massy, France. As of November 12, 2007, Ipracom SA is a subsidiary of Maeglin Software.
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim. Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analogue for the treatment of Type 2 diabetes, is marketed globally outside the US as Lyxumia:registered: by Sanofi and under regulatory review in the US. The license collaboration with Sanofi covers also a single-product combination of lixisenatide and insulin glargine (Lantus:registered:) which is on track for regulatory submission in the US in December 2015 and in the European Union in Q1 2016. The proprietary pipeline includes; danegaptide for ischemic reperfusion Injuries in Phase II development; ZP1848 for Short Bowel Syndrome in Phase II development; and the stable glucagon analogue, ZP4207, in Phase II preparation both as a single-dose rescue pen for severe hypoglycemia and for multiple-dose use to treat and control mild to moderate hypoglycemia; as well as several preclinical peptide therapeutics. The company is based in Copenhagen (Glostrup), Denmark. For further information about Zealand’s business and activities, please visit: www.zealandpharma.com or follow us on Twitter @ZealandPharma
Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off of the Eidgenössische Technische Hochschule Zürich (ETHZ), Kuros has developed a pipeline of products based upon its proprietary technology platforms. These platforms were developed from work carried out at ETHZ, at the University of Zürich and at the California Institute of Technology (CalTech). In addition, in early 2017 Kuros acquired Xpand Biotechnology to gain access to its MagnetOs family of bone graft substitutes and the associated surface science technology. Kuros has attractive commercial prospects in key market segments as well as an EU hub for future clinical and distribution operations. The company is in transition to commercial stage with one product having marketing approval in the EU and US and further product expected to achieve EU approval this year. MagnetOs is approved for sale in the EU for orthopedic, spine and dental applications, and in the US for posterolateral spinal fusion. In addition, a putty formulation is being prepared for submission in the EU and the US in the second half of this year. Neuroseal, a novel biomaterial for dural sealing, is Kuros’ second product and currently under review for CE marking in the EU. Kuros has also assembled a pipeline of clinical stage programs in various stages of development and amassed significant clinical and preclinical data in a number of indications and applications primarily in the area of orthobiologics. The Company has enrolled over 600 patients in multinational clinical trials, and has generated promising safety and efficacy in a number of significant indications.
Radio Systemes Ingenierie
Series C in 2004
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions.
Roctool is a technology and manufacturing solutions provider offering engineering services and systems for injection and compression molding. Its Research and Development team is constantly adapting its induction technologies to more materials in order to draw benefits such as reduced cycle times, enhanced surface quality,lightweighting, product performance, and overall cost reductions. Roctool’s latest technology, IDH™ - Induction Dual Heating, is a leading heat and cool process combining composites with overmolded plastic features, which targets major brands in innovative industries, e.g. automotive, aerospace, consumer products, and electronics. Roctool’s technologies are already in production, in particular HD Plastics™ capabilities for plastic molding and Light Induction Tooling - LIT™ for composite parts. Roctool is listed on Alternext. Its headquarters and R&D center is situated at Le Bourget du Lac (France). Roctool also has offices and platforms in North America, Japan, Taiwan, and Germany.
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions.
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.
Teem Photonics develops passively Q-switched microlasers as well as Photonics Integrated Circuits based on ion exchange technology. The combination of passive Q-switching and microlaser technologies results in sources distinctive for sub nanosecond, high peak power pulses, generated from compact packages at high repetition rates.
Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Founded in 2000 as a spin-off of the Eidgenössische Technische Hochschule Zürich (ETHZ), Kuros has developed a pipeline of products based upon its proprietary technology platforms. These platforms were developed from work carried out at ETHZ, at the University of Zürich and at the California Institute of Technology (CalTech). In addition, in early 2017 Kuros acquired Xpand Biotechnology to gain access to its MagnetOs family of bone graft substitutes and the associated surface science technology. Kuros has attractive commercial prospects in key market segments as well as an EU hub for future clinical and distribution operations. The company is in transition to commercial stage with one product having marketing approval in the EU and US and further product expected to achieve EU approval this year. MagnetOs is approved for sale in the EU for orthopedic, spine and dental applications, and in the US for posterolateral spinal fusion. In addition, a putty formulation is being prepared for submission in the EU and the US in the second half of this year. Neuroseal, a novel biomaterial for dural sealing, is Kuros’ second product and currently under review for CE marking in the EU. Kuros has also assembled a pipeline of clinical stage programs in various stages of development and amassed significant clinical and preclinical data in a number of indications and applications primarily in the area of orthobiologics. The Company has enrolled over 600 patients in multinational clinical trials, and has generated promising safety and efficacy in a number of significant indications.
Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.
Santen specializes in the research, development, marketing, and sales of innovative eye care products and services that enable optimal sight. They help physicians address the complex clinical challenges in vision care with novel solutions for glaucoma, retinal diseases, and other eye conditions.
6WIND is a leading high-performance networking software company and the worldwide market leader for vRouter solutions. 6WIND software is deployed globally by Service Providers, Cloud Providers, Systems Integrators, Enterprises and Tier-1 OEMs, allowing customers to replace expensive hardware with software and virtualization for routing and security use cases. 6WIND has a global presence with Headquarters based in Paris, France and in Santa Clara, California. For more information visit: http://www.6wind.com